Citigroup’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-248,768
| Closed | -$42.8M | – | 5385 |
|
|
2021
Q3 | $42.8M | Buy |
248,768
+198,437
| +394% | +$34.2M | 0.03% | 416 |
|
|
2021
Q2 | $6.32M | Buy |
50,331
+4,354
| +9% | +$546K | ﹤0.01% | 1276 |
|
|
2021
Q1 | $6.24M | Buy |
45,977
+18,714
| +69% | +$2.54M | ﹤0.01% | 1224 |
|
|
2020
Q4 | $3.49M | Sell |
27,263
-27,990
| -51% | -$3.58M | ﹤0.01% | 1410 |
|
|
2020
Q3 | $6.22M | Sell |
55,253
-39,012
| -41% | -$4.39M | ﹤0.01% | 1054 |
|
|
2020
Q2 | $8.98M | Buy |
94,265
+58,924
| +167% | +$5.61M | 0.01% | 830 |
|
|
2020
Q1 | $3.18M | Sell |
35,341
-8,530
| -19% | -$767K | ﹤0.01% | 1154 |
|
|
2019
Q4 | $2.33M | Sell |
43,871
-9,649
| -18% | -$512K | ﹤0.01% | 1582 |
|
|
2019
Q3 | $2.12M | Sell |
53,520
-19,510
| -27% | -$771K | ﹤0.01% | 1577 |
|
|
2019
Q2 | $3M | Buy |
73,030
+57,029
| +356% | +$2.34M | ﹤0.01% | 1357 |
|
|
2019
Q1 | $745K | Sell |
16,001
-120,334
| -88% | -$5.6M | ﹤0.01% | 2197 |
|
|
2018
Q4 | $5.94M | Buy |
136,335
+128,787
| +1,706% | +$5.61M | 0.01% | 936 |
|
|
2018
Q3 | $432K | Sell |
7,548
-11,969
| -61% | -$685K | ﹤0.01% | 2648 |
|
|
2018
Q2 | $947K | Sell |
19,517
-19,292
| -50% | -$936K | ﹤0.01% | 1917 |
|
|
2018
Q1 | $1.52M | Sell |
38,809
-12,828
| -25% | -$502K | ﹤0.01% | 1584 |
|
|
2017
Q4 | $2.19M | Sell |
51,637
-806,656
| -94% | -$34.2M | ﹤0.01% | 1418 |
|
|
2017
Q3 | $32M | Buy |
858,293
+830,721
| +3,013% | +$31M | 0.03% | 310 |
|
|
2017
Q2 | $838K | Buy |
27,572
+7,102
| +35% | +$216K | ﹤0.01% | 2093 |
|
|
2017
Q1 | $541K | Sell |
20,470
-66,014
| -76% | -$1.74M | ﹤0.01% | 2362 |
|
|
2016
Q4 | $2.21M | Buy |
86,484
+74,987
| +652% | +$1.91M | ﹤0.01% | 1754 |
|
|
2016
Q3 | $416K | Buy |
11,497
+1,783
| +18% | +$64.5K | ﹤0.01% | 2554 |
|
|
2016
Q2 | $330K | Sell |
9,714
-11,777
| -55% | -$400K | ﹤0.01% | 2508 |
|
|
2016
Q1 | $568K | Buy |
21,491
+11,326
| +111% | +$299K | ﹤0.01% | 2581 |
|
|
2015
Q4 | $496K | Buy |
10,165
+5,346
| +111% | +$261K | ﹤0.01% | 2349 |
|
|
2015
Q3 | $120K | Sell |
4,819
-5,498
| -53% | -$137K | ﹤0.01% | 3072 |
|
|
2015
Q2 | $326K | Sell |
10,317
-2,496
| -19% | -$78.9K | ﹤0.01% | 2436 |
|
|
2015
Q1 | $488K | Sell |
12,813
-3,564
| -22% | -$136K | ﹤0.01% | 2311 |
|
|
2014
Q4 | $638K | Buy |
16,377
+11,577
| +241% | +$451K | ﹤0.01% | 2219 |
|
|
2014
Q3 | $145K | Buy |
4,800
+1,285
| +37% | +$38.8K | ﹤0.01% | 2861 |
|
|
2014
Q2 | $119K | Sell |
3,515
-858
| -20% | -$29K | ﹤0.01% | 2968 |
|
|
2014
Q1 | $151K | Sell |
4,373
-836
| -16% | -$28.9K | ﹤0.01% | 3138 |
|
|
2013
Q4 | $207K | Buy |
+5,209
| New | +$207K | ﹤0.01% | 3121 |
|